北美深蓝
liked and commented on
🔴According to the clinical trial results announcement disclosed by the company on November 20, combined with the contents of the telephone conference held on the same day, the results of the clinical trial are summarized below.
⭕My conclusion is bullish. The stock price fell today, perhaps to clear unstable chips for the next round of upward movement. Currently, the long-term moving average is strong support. After thorough cleaning, there will be a period of consolidation, followed by another uptrend, then a new round of financing to raise funds for commercialization outside Europe and further expansion of phase III clinical trials for NDA new drug applications. Of course, the possibility of the company being acquired at a substantial premium cannot be ruled out. Turbo is heavily weighted, continue to hold.
🔴Intoday's telephone conference, company management and Professor John Kastelein emphasized the synergistic effect of obicetrapib when used in combination with evolocumab. This means that the combined effect of the drugs is superior to the sum of the effects of the two drugs used alone. The management stated that the positive results of the TANDEM trial have strengthened the company's confidence in the ongoing PREVAIL trial. Once PREVAIL is successful in the future, the company valuation is expected to double.
————
🔥Interpretation of TANDEM Trial Results🔥
🔴Primary Endpoint: Percentage Reduction in LDL-C
Day 84:
Monotherapy with Evymlozumab: LDL-C decreased by 23.3% compared to placebo.
Monotherapy with Obicetrapib: LDL-C decreased by 31.5% compared to placebo.
O...
⭕My conclusion is bullish. The stock price fell today, perhaps to clear unstable chips for the next round of upward movement. Currently, the long-term moving average is strong support. After thorough cleaning, there will be a period of consolidation, followed by another uptrend, then a new round of financing to raise funds for commercialization outside Europe and further expansion of phase III clinical trials for NDA new drug applications. Of course, the possibility of the company being acquired at a substantial premium cannot be ruled out. Turbo is heavily weighted, continue to hold.
🔴Intoday's telephone conference, company management and Professor John Kastelein emphasized the synergistic effect of obicetrapib when used in combination with evolocumab. This means that the combined effect of the drugs is superior to the sum of the effects of the two drugs used alone. The management stated that the positive results of the TANDEM trial have strengthened the company's confidence in the ongoing PREVAIL trial. Once PREVAIL is successful in the future, the company valuation is expected to double.
————
🔥Interpretation of TANDEM Trial Results🔥
🔴Primary Endpoint: Percentage Reduction in LDL-C
Day 84:
Monotherapy with Evymlozumab: LDL-C decreased by 23.3% compared to placebo.
Monotherapy with Obicetrapib: LDL-C decreased by 31.5% compared to placebo.
O...
Translated
12
3
北美深蓝
liked and commented on
$Wolfspeed (WOLF.US)$
Such a high level of short positions!
The quarterly candlestick continues to trend downward!
Long-term liabilities exceed $6 billion!
Possible plan: Observe at $5.2 for the trading position, $4.5 for the venture capital position.
Such a high level of short positions!
The quarterly candlestick continues to trend downward!
Long-term liabilities exceed $6 billion!
Possible plan: Observe at $5.2 for the trading position, $4.5 for the venture capital position.
Translated
11
3
北美深蓝
commented on
$Wolfspeed (WOLF.US)$ price should hover $6-$7. Close eyes and expect 2X return 2nd half 2025. Let’s gamble.
5
2
北美深蓝
voted
Hi mooers!
$PDD Holdings (PDD.US)$ is releasing its Q3 earnings on November 21 before the bell. Unlock insights with PDD Earnings Hub>>
$PDD Holdings (PDD.US)$' share prices often fluctuate a lot around earnings releases, like the +18.08% jump after 2023 Q3 earnings, and the -28.51% drop after 2024 Q3 earnings results. Amid recent economic stimulus policies from the Chinese government, how would this famous Chinese e-commerce co...
$PDD Holdings (PDD.US)$ is releasing its Q3 earnings on November 21 before the bell. Unlock insights with PDD Earnings Hub>>
$PDD Holdings (PDD.US)$' share prices often fluctuate a lot around earnings releases, like the +18.08% jump after 2023 Q3 earnings, and the -28.51% drop after 2024 Q3 earnings results. Amid recent economic stimulus policies from the Chinese government, how would this famous Chinese e-commerce co...
32
21
北美深蓝
voted
Hi mooers!
Need a quick update on this week's events? Check out moomoo's fresh earnings & economic calendars to start this week!
For more details, check out the earnings calendar and economic calendar!
This week, various companies including $Walmart (WMT.US)$ , $NVIDIA (NVDA.US)$ , $XPeng (XPEV.US)$ and $NIO Inc (NIO.US)$ are releasing their earnings. How will the market react to the companies' results? Let's make a guess!
For m...
Need a quick update on this week's events? Check out moomoo's fresh earnings & economic calendars to start this week!
For more details, check out the earnings calendar and economic calendar!
This week, various companies including $Walmart (WMT.US)$ , $NVIDIA (NVDA.US)$ , $XPeng (XPEV.US)$ and $NIO Inc (NIO.US)$ are releasing their earnings. How will the market react to the companies' results? Let's make a guess!
For m...
15
11
北美深蓝
voted
Spoiler: Stay tuned until the end for a chance to earn bonus points!
Hello mooers,
As we conclude the exhilarating final week of our Global Paper Trading Challenge, it's been a phenomenal journey observing the robust engagement and strategic prowess displayed by our participants. Let's dive into this week's wrap-up, which brings some exciting twists and opportunities for a strong finish!
Final Push with Props and Rewards
This i...
Hello mooers,
As we conclude the exhilarating final week of our Global Paper Trading Challenge, it's been a phenomenal journey observing the robust engagement and strategic prowess displayed by our participants. Let's dive into this week's wrap-up, which brings some exciting twists and opportunities for a strong finish!
Final Push with Props and Rewards
This i...
+2
69
53
北美深蓝
voted
Hi, mooers!
Welcome back to Maple Market Challenge!
First, let’s examine last week’s vote: What do you like about Air Canada? A whopping 82% of mooers like the stock price soaring after earnings, while just 18% like the actual flying experience. Really? Don’t just take our word for it—head to the comments for some entertaining insights!
All of our mooers who voted will receive 10 poin...
Welcome back to Maple Market Challenge!
First, let’s examine last week’s vote: What do you like about Air Canada? A whopping 82% of mooers like the stock price soaring after earnings, while just 18% like the actual flying experience. Really? Don’t just take our word for it—head to the comments for some entertaining insights!
All of our mooers who voted will receive 10 poin...
20
24
北美深蓝
voted
Hi mooers!
$Occidental Petroleum (OXY.US)$ is releasing its Q3 earnings on November 13 after the bell. Unlock insights with OXY Earnings Hub>>
Over the last 2 years, OXY has beaten EPS estimates 50% of the time and has beaten revenue estimates 38% of the time. Amid recent oil price fluctuations, how would $Occidental Petroleum (OXY.US)$ perform? What guidance will the management provide? Subscribe to @Moo Live and book the confe...
$Occidental Petroleum (OXY.US)$ is releasing its Q3 earnings on November 13 after the bell. Unlock insights with OXY Earnings Hub>>
Over the last 2 years, OXY has beaten EPS estimates 50% of the time and has beaten revenue estimates 38% of the time. Amid recent oil price fluctuations, how would $Occidental Petroleum (OXY.US)$ perform? What guidance will the management provide? Subscribe to @Moo Live and book the confe...
67
102
北美深蓝
voted
Hi mooers!
$MARA Holdings (MARA.US)$ is releasing its Q3 earnings on November 12 after the bell. Unlock insights with MARA Earnings Hub>>
$MARA Holdings (MARA.US)$ produced 717 Bitcoins with $48.8M worth in October, reaching a historical high. As $Bitcoin (BTC.CC)$ price surpassed $80,000 for the first time on November 10, how will the famous Bitcoin miner perform? Subscribe to @Moo Live and book the conference call!
For the ...
$MARA Holdings (MARA.US)$ is releasing its Q3 earnings on November 12 after the bell. Unlock insights with MARA Earnings Hub>>
$MARA Holdings (MARA.US)$ produced 717 Bitcoins with $48.8M worth in October, reaching a historical high. As $Bitcoin (BTC.CC)$ price surpassed $80,000 for the first time on November 10, how will the famous Bitcoin miner perform? Subscribe to @Moo Live and book the conference call!
For the ...
27
44
北美深蓝
voted
Hi, mooers!
$Shopify (SHOP.US)$ $Shopify Inc (SHOP.CA)$ is releasing its Q3 2024 earnings on Nov 12 before the bell. Book the conference call: Shopify Q3 2024 earnings conference call
How will the market react to the upcoming results? Make your guess now!
Rewards
🎁 20 points: For mooers who correctly guess the price range of $Shopify (SHOP.US)$'s closing price at 16:00 PM ET Nov 12.
(Vote will close on 15:59 ET November 12)
🎁 Exc...
$Shopify (SHOP.US)$ $Shopify Inc (SHOP.CA)$ is releasing its Q3 2024 earnings on Nov 12 before the bell. Book the conference call: Shopify Q3 2024 earnings conference call
How will the market react to the upcoming results? Make your guess now!
Rewards
🎁 20 points: For mooers who correctly guess the price range of $Shopify (SHOP.US)$'s closing price at 16:00 PM ET Nov 12.
(Vote will close on 15:59 ET November 12)
🎁 Exc...
Expand
22
40
北美深蓝 OP : Information related to the PREVAIL trial:
The design of the PREVAIL trial refers to the lessons learned from previous CETP inhibitor CVOT failures, using stricter inclusion criteria and longer follow-up time to increase the chances of trial success.
The company expects to announce the PREVAIL trial data in 2026.
As of April 2024, the PREVAIL trial has achieved its recruitment target of 9,000 patients and extended recruitment until the end of April, with over 9,500 patients randomized.
———The purpose of designing the PREVAIL trial by the company is to validate the efficacy of obicetrapib in reducing MACE, support its marketing application, and future market promotion. Once successful, this trial can prove that obicetrapib can bring clinical benefits to ASCVD patients and make it stand out in competition with other lipid-lowering drugs.
北美深蓝 OP : Based on yesterday's trading volume (3.01 million shares), short sell ratio (8.07%), and previous trends, combined with the company's previous disclosure of information, it may be a well-planned insider trading that complies with the rules.
Intentional price manipulation before the disclosure of clinical results, followed by the result release, triggering the rules, selling off (or transferring chips to buyers), causing the stock price to drop, but the drop is within the expected range, ending the selling and starting the next trend.
During this decline, the lowest price is higher than the issuance price at the beginning of the year.
On March 28, 2024, NAP PoolCo B.V. ("PoolCo") adopted a 10b5-1 rule trading plan that could involve selling up to 2.95 million shares of the company's common stock, subject to certain price thresholds and other conditions. The purpose of this plan is to allow insiders to sell their held company stocks without violating insider trading laws. The estimated decline this time may be related to this, and the set thresholds may be related to the clinical result disclosure this time.
Here is more information on the 10b5-1 rule and the pre-arranged trading plan under this rule:
10b5-1 Rule: The 10b5-1 Rule is a rule established by the U.S. Securities and Exchange Commission (SEC) that allows company insiders (such as executives and directors) to buy and sell company stock under a preset plan, even if they later obtain inside information. The rule requires insiders to not have any insider information when formulating the trading plan, and they must submit it to the SEC before the plan takes effect.
Trading Arrangement: The 10b5-1 rule trading arrangement adopted by PoolCo allows for the sale of up to 2.95 million shares of the company's common stock under certain pre-set conditions (such as price thresholds and other conditions, but this detail is not disclosed in the company's disclosures).
Purpose: The purpose of this arrangement is to provide PoolCo with a way to sell its held company stocks without violating insider trading laws. This also helps insiders conduct stock transactions without causing speculation in the market about their stock holding intentions.
Timing: The trades under this arrangement may not begin earlier than 90 days after its adoption or two business days after the submission of the quarterly report on Form 10-Q. The expiration date of this arrangement is June 28, 2026.
PoolCo Background: PoolCo is a Dutch limited liability company representing its shareholders holding the company's common stocks, controlled by Forbion International Management B.V., and Sander Slootweg, a board member of the company, is one of the directors of Forbion International Management B.V.